Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$1.46 - $2.25 $422,232 - $650,700
-289,200 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$1.77 - $2.93 $50,868 - $84,205
-28,739 Reduced 9.04%
289,200 $518,000
Q4 2020

Feb 02, 2021

BUY
$2.13 - $3.26 $48,434 - $74,129
22,739 Added 7.7%
317,939 $680,000
Q3 2020

Nov 05, 2020

BUY
$1.53 - $3.13 $260,406 - $532,726
170,200 Added 136.16%
295,200 $883,000
Q3 2017

Nov 15, 2017

BUY
$2.22 - $2.79 $277,500 - $348,750
125,000
125,000 $319,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $313M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.